Login / Signup

A chameleonic macrocyclic peptide with drug delivery applications.

Colton D PayneBastian FrankeMark F FisherFatemeh HajiaghaalipourCourtney E McAleeseAngela SongCarl EliassonJingjing ZhangAchala S JayasenaGrishma VadlamaniRichard J ClarkRodney F MinchinJoshua S MylneK Johan Rosengren
Published in: Chemical science (2021)
Head-to-tail cyclized peptides are intriguing natural products with unusual properties. The PawS-Derived Peptides (PDPs) are ribosomally synthesized as part of precursors for seed storage albumins in species of the daisy family, and are post-translationally excised and cyclized during proteolytic processing. Here we report a PDP twice the typical size and with two disulfide bonds, identified from seeds of Zinnia elegans. In water, synthetic PDP-23 forms a unique dimeric structure in which two monomers containing two β-hairpins cross-clasp and enclose a hydrophobic core, creating a square prism. This dimer can be split by addition of micelles or organic solvent and in monomeric form PDP-23 adopts open or closed V-shapes, exposing different levels of hydrophobicity dependent on conditions. This chameleonic character is unusual for disulfide-rich peptides and engenders PDP-23 with potential for cell delivery and accessing novel targets. We demonstrate this by conjugating a rhodamine dye to PDP-23, creating a stable, cell-penetrating inhibitor of the P-glycoprotein drug efflux pump.
Keyphrases
  • drug delivery
  • single cell
  • cell therapy
  • amino acid
  • cancer therapy
  • ionic liquid
  • minimally invasive
  • emergency department
  • mesenchymal stem cells
  • climate change
  • drug release
  • risk assessment
  • bone marrow
  • water soluble